[
    [
        {
            "time": "2020-05-14",
            "original_text": "午间公告2020年5月14日星期四",
            "features": {
                "keywords": [
                    "华大基因",
                    "全资子公司",
                    "医疗器械注册证变更"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "午间公告2020年5月14日星期四",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "百度AI发布颠覆性疫苗基因优化设计算法 加速新冠疫苗研发（股）",
            "features": {
                "keywords": [
                    "百度AI",
                    "疫苗",
                    "基因优化设计算法",
                    "新冠疫苗研发"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "百度AI发布颠覆性疫苗基因优化设计算法 加速新冠疫苗研发（股）",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "存货应收双增，疫情下的华大基因，到底是昙花一现还是王者归来？",
            "features": {
                "keywords": [
                    "华大基因",
                    "存货应收双增",
                    "疫情"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "存货应收双增，疫情下的华大基因，到底是昙花一现还是王者归来？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "投资者提问：请问，华大基因持有华大因源的63.53%的股份，像新冠肺炎病毒",
            "features": {
                "keywords": [
                    "华大基因",
                    "华大因源",
                    "股份持有",
                    "新冠肺炎病毒"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "投资者提问：请问，华大基因持有华大因源的63.53%的股份，像新冠肺炎病毒",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]